Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
visible-on: Access Campaign
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
Read More
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Read More
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Read More
ASEAN and India urged not to trade away people’s lives in trade agreement
Read More
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
Read More
MSF statement on resumption of EU-India FTA negotiations
Read More
MSF responds to India’s first-ever national anti-tuberculosis drug resistance survey
Read More
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
Read More
Indian patent office delivers major blow to affordable pneumonia vaccine hopes
Read More
Doctors Without Borders urges India’s Modi to remain committed to affordable medicines during White House meeting
Read More